Quantum BioPharma reports $11.3 million cash runway through January 2028 Mar 27, 2026 08:11AM
Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status Mar 27, 2026 08:10AM
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio Nov 7, 2025 07:00AM
Quantum BioPharma warrants expire, confirms CVR record date Oct 20, 2025 08:31AM
Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend Oct 20, 2025 08:30AM


Oct 20, 2025 08:30AM Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend
Oct 8, 2025 08:03AM Quantum BioPharma offers $7 million reward for stock manipulation proof
Oct 8, 2025 08:00AM Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock